Inventor · disambiguated record
Timothy C. Gahman
Also filed as: GAHMAN TIMOTHY · GAHMAN TIMOTHY C
10 granted patents·10 pending applications·196 citations·filing 1999–2018
88Inventor score
Files withKALYPSYS INC9HARVARD COLLEGE4LION BIOSCIENCE AG3LUDWIG INST FOR CANCER RES LTD2FINLEY DANIEL J1
Top patents by PatentIndex Score
20 records- 0192US10351568B2Compositions and methods for enhancing proteasome activityHARVARD COLLEGE·Filed 2015·Granted Jul 16, 2019·14 cites·8 claims
- 0292US6534503B1Melanocortin receptor-3 ligands to treat sexual dysfunctionLION BIOSCIENCE AG·Filed 2000·Granted Mar 18, 2003·75 cites·71 claims
- 0390US6127381AIsoquinoline compound melanocortin receptor ligands and methods of using sameFiled 1999·Granted Oct 3, 2000·68 cites·69 claims
- 0489US6768024B1Triamine derivative melanocortin receptor ligands and methods of using sameLION BIOSCIENCE AG·Filed 2000·Granted Jul 27, 2004·28 cites·19 claims
- 0568US8933087B2Tricyclic proteasome activity enhancing compoundsFINLEY DANIEL J·Filed 2011·Granted Jan 13, 2015·2 cites·29 claims
- 0665US2010094021A1Novel method of preparation of 5-chloro-3-imidazol-1-yl-[1,2,4]thiadiazole and (3-imidazol-1-yl-[1,2,4]thiadiazol-5yl)-dialkyl-aminesKALYPSYS INC·Filed 2009·Application pending·0 cites
- 0760US9981981B2Tricyclic proteasome activity enhancing compoundsHARVARD COLLEGE·Filed 2014·Granted May 29, 2018·0 cites·16 claims
- 0857US2007123572A1Novel method of preparation of 5-chloro-3-imidazol-1-yl-[1,2,4]thiadiazole and (3-imidazol-1-yl-[1,2,4]thiadiazol-5yl)-dialkyl-aminesKALYPSYS INC·Filed 2006·Application pending·0 cites
- 0955US2018265519A1Tricyclic proteasome activity enhancing compoundsHARVARD COLLEGE·Filed 2018·Application pending·0 cites
- 1051US6608082B1Treatment of erectile dysfunction using isoquinoline compound melanocortin receptor ligandsLION BIOSCIENCE AG·Filed 1999·Granted Aug 19, 2003·9 cites·9 claims
- 1150US2009209536A1Aminoquinazoline cannabinoid receptor modulators for treatment of diseaseKALYPSYS INC·Filed 2008·Application pending·0 cites
- 1249US2009062253A1Heterocyclodiazepine cannabinoid receptor modulators for treatment of diseaseKALYPSYS INC·Filed 2008·Application pending·0 cites
- 1347US2007049591A1Inhibitors of MAPK/Erk KinaseKALYPSYS INC·Filed 2006·Application pending·0 cites
- 1446US2007155746A1Novel substituted pyridinyloxy and pyrimidinyloxy amides useful as inhibitors of protein kinasesKALYPSYS INC·Filed 2006·Application pending·0 cites
- 1544US2013045992A1Compositions and Methods for Enhancing Proteasome ActivityHARVARD COLLEGE·Filed 2011·Application pending·0 cites
- 1643US2007155764A1Novel substituted pyrimidinyloxy ureas useful as inhibitors of protein kinasesKALYPSYS INC·Filed 2006·Application pending·0 cites
- 1740US11253521B23-hydroxy-quinazoline-2,4-dione derivatives and their use as nuclease modulatorsLUDWIG INST FOR CANCER RES LTD·Filed 2016·Granted Feb 22, 2022·0 cites·20 claims
- 1838US10752612B2PLK4 inhibitorsLUDWIG INST FOR CANCER RES LTD·Filed 2016·Granted Aug 25, 2020·0 cites·20 claims
- 1937US2007197609A1Salts of inducible nitric oxide synthase dimerization inhibitorsKALYPSYS INC·Filed 2006·Application pending·0 cites
- 2036US7825256B2Inducible nitric oxide synthase dimerization inhibitorsKALYPSYS INC·Filed 2005·Granted Nov 2, 2010·0 cites·20 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →